Curis
CRIS
#11244
Rank
โ‚น0.13 B
Marketcap
โ‚น56.97
Share price
9.39%
Change (1 day)
-56.86%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): -โ‚น1,381

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น1,350. In 2025 the company made an earnings per share (EPS) of -โ‚น2,261 an increase over its 2024 EPS that were of -โ‚น13,350.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น1,381-38.91%
2025-โ‚น2,261-83.07%
2024-โ‚น13,350-22.15%
2023-โ‚น17,148-26.17%
2022-โ‚น23,22522.3%
2021-โ‚น18,990-25.37%
2020-โ‚น25,447-30.93%
2019-โ‚น36,841-2.02%
2018-โ‚น37,600
2016-โ‚น85,455-10%
2015-โ‚น94,950138.1%
2014-โ‚น39,87940%
2013-โ‚น28,485-25%
2012-โ‚น37,98066.67%
2011-โ‚น22,788

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น72.16-105.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น431.07-131.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น34.18-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น313.33-123.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น413.03-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น301.94-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-โ‚น326.63-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA